Feed & Additive Magazine Issue 3 April 2021

NEWS FEED & ADDITIVE MAGAZINE April 2021 11 Kemin becomes majority shareholder in animal vaccine company MEVAC Kemin Industries is focusing on strengthening its place in the global vaccine manufacturing and distribution market with its increased partnership in Middle East for Vaccines (MEVAC) and investment in its sister company. K emin Industries, a global ingredient manufacturer that strives to sustainably trans- form the quality of life every day for 80 percent of the world with its products and services, is growing its presence in the glob- al vaccine market by becoming majority shareholder of MEVAC, an animal vaccine manufactur- er based in Cairo, Egypt, and a shareholder in MEVAC's sister company, UVAC, to further ex- pand Kemin's portfolio in the global animal vaccine market. First investing in the MEVAC in 2010, Kemin has increased its par- ticipation in the Egyptian-based company over the years. In 2019, Kemin increased its share in ME- VAC and received the right to dis- tribute its vaccines globally, out- side the Arabic-speaking countries in the Middle East already served by MEVAC. As part of its investment in ME- VAC, Kemin has access to a mod- ern vaccine plant with production and R&D capabilities to support future growth. UVAC, MEVAC's sister company, also in Egypt, and in which Kemin is a shareholder, has been established to produce foot-and-mouth disease and tis- sue-culture vaccines for animals, as well as human vaccines. A lign Capital Partners (ACP) announced the majority recapitalization of Custom Vet- erinary Services (CVS), a custom formulator and contract manufacturer exclusively focused on the animal health industry. The Company’s FDA-reg- istered facility in Miami, Florida produces nutri- tional supplements, dermatological, and grooming products for companion animals. Founded by Ruben Martinez in 2005, CVS serves customers ranging from well-established animal health organizations to prospering e-commerce-fo- cused brands. Under Ruben’s leadership, the Com- pany has partnered with over 100 clients to date; working with them to identify their product needs, develop formulations, establish packaging, and scale up to production. “CVS’ commitment is to produce the highest quality products and service for our customers,” said Ruben Martinez, President of CVS. “Our customers are growing rapidly, and we sought a partner to help us expand and further meet our customers' needs. ACP and Worth Turner have a successful track record of helping companies like CVS grow and share our vision of being the best contract manufacturing partner for the animal health industry.” ACP invests in animal health with CVS